Symbol
CNTX on Nasdaq
Investment type
Equity / Common Stock
Latest Disclosed Shares Owned
4,776,398 shares
Security Ownership %
5.2%

Soleus Capital Master Fund, L.P. ownership in Context Therapeutics Inc. Common Stock (CNTX)

03 Feb 2026 - Soleus Capital Master Fund, L.P. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,776,398 shares of Context Therapeutics Inc. Common Stock (CNTX). This represents 5.2% ownership of the company. This is the first filing by Soleus Capital Master Fund, L.P. disclosing ownership of Context Therapeutics Inc. Common Stock (CNTX).